Monthly Archives: April 2017

How can Minority Participation be Increased in Clinical Trials?

Twenty tree years after the NIH created the Revitalization Act to increase the number of women and minorities in clinical trials, they still seem under-represented in drug trials. Is that still the case? There were some well-known drug trials where minorities were mistreated. Women were not even allowed to participate in trials for a long […]

How Would the Trump Administration Affect Clinical Trials?

The new Trump Administration will be overseeing clinical drug policy. The big question is: How will this new administration affect clinical trials? Clinical trials are rarely influenced by the politics. Most clinical trial rules are fifty years old and well-established as are international standards. . The Trump Administration has talked about cost reduction of drugs. […]